A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
2 天
News Medical on MSNResearchers develop mouse model to study neutrophilic asthmaA better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
1 天
News Medical on MSNNew therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma ...Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...
Researchers are tackling neutrophilic asthma, successfully developing one of the first mouse models of the condition.
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Millions of Brits live with asthma and rely on a variety of treatments to manage their condition, but a new study has raised ...
Roughly 28 million individuals in the United States are diagnosed with asthma. Despite the disease’s prevalence being higher in children, the overall | Immunology ...
A team of researchers have discovered a new 'cocktail' of drugs that could help those with asthma and other respiratory issues.
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Two therapeutic "cocktails" could stop immune cells from overreacting to allergens, providing long-lasting asthma relief.
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果